Similar articles

• [Clinical course of 8 patients with intravascular large B-cell lymphoma diagnosed while alive].

  Ohshima R, Tomita N, Motohashi K, Ieda A, Hyou R, Fujisawa S, Fujita H, Sakai R, Koharazawa H, Kuwabara H, Kanamori H, Ishigatsubo Y. Ohshima R, et al. Rinsho Ketsueki. 2005 Jun;46(6):453-7. Rinsho Ketsueki. 2005. PMID: 16447727 Review. Japanese.
• Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.

  Feldmann R, Schierl M, Sittenthaler M, Jahn R, Wogritsch C, Cerroni L, Steiner A, Breier F. Feldmann R, et al. Dermatology. 2009;219(4):344-6. doi: 10.1159/000228328. Epub 2009 Jul 8. Dermatology. 2009. PMID: 19590171
• [Diagnosis of intravascular lymphoma: usefulness of random skin biopsies].

  Namekawa M, Nakano I. Namekawa M, et al. Brain Nerve. 2011 May;63(5):451-8. Brain Nerve. 2011. PMID: 21515924 Review. Japanese.
• [Intravascular large B-cell lymphoma with massive pulmonary lesions].

  Higashiyama A, Hashino S, Onozawa M, Takahata M, Okada K, Kahata K, Taniguchi N, Nasuhara Y, Kubota K, Fujimoto N, Matsuno Y, Nishimura M, Asaka M. Higashiyama A, et al. Rinsho Ketsueki. 2010 May;51(5):353-6. Rinsho Ketsueki. 2010. PMID: 20534958 Review. Japanese.
• Durable remission of intravascular lymphoma with central nervous system involvement following chemotherapy and rituximab.

  Go A, Venugopal P, Loew J, Djordjevic D. Go A, et al. Clin Adv Hematol Oncol. 2006 Jun;4(6):439-41. Clin Adv Hematol Oncol. 2006. PMID: 16981666 No abstract available.